Congress Wealth Management LLC DE Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Congress Wealth Management LLC DE raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,494 shares of the medical equipment provider’s stock after buying an additional 217 shares during the period. Congress Wealth Management LLC DE’s holdings in Intuitive Surgical were worth $16,560,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Vanguard Group Inc. boosted its position in shares of Intuitive Surgical by 0.7% during the third quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after buying an additional 196,316 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Intuitive Surgical by 1.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock valued at $5,726,102,000 after purchasing an additional 272,741 shares during the period. Edgewood Management LLC boosted its holdings in shares of Intuitive Surgical by 7.9% in the fourth quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock valued at $1,731,016,000 after purchasing an additional 374,667 shares during the period. Fisher Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 2.0% in the fourth quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock valued at $1,516,222,000 after purchasing an additional 88,977 shares during the period. Finally, Norges Bank purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $1,313,238,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.9 %

Shares of ISRG traded down $8.61 during trading hours on Monday, reaching $436.24. 1,657,860 shares of the company traded hands, compared to its average volume of 1,528,116. The stock has a market capitalization of $154.73 billion, a P/E ratio of 78.96, a P/E/G ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $448.10. The business has a fifty day moving average price of $403.83 and a 200-day moving average price of $383.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The firm had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period in the previous year, the company earned $1.00 earnings per share. The business’s quarterly revenue was up 11.5% compared to the same quarter last year. As a group, research analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction on Friday, April 26th. The shares were sold at an average price of $369.92, for a total value of $554,140.16. Following the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,037,149.44. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 1,498 shares of the company’s stock in a transaction on Friday, April 26th. The shares were sold at an average price of $369.92, for a total value of $554,140.16. Following the sale, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at $2,037,149.44. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 5,318 shares of the stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the sale, the executive vice president now directly owns 298 shares in the company, valued at $110,456.68. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,956 shares of company stock valued at $6,927,011. 0.80% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on ISRG shares. Citigroup boosted their price target on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. The Goldman Sachs Group started coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 price objective for the company. Piper Sandler boosted their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research note on Friday, April 19th. Robert W. Baird reduced their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research note on Friday, April 19th. Finally, BTIG Research boosted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $403.67.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.